Shanghai Chest Hospital: clinical-trial pipeline
Shanghai Chest Hospital is the sponsor of 197 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 95 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 121 |
| Phase 2 | 48 |
| Phase 3 | 9 |
| Phase 1/2 | 8 |
| Phase 4 | 5 |
| Phase 1 | 3 |
| Phase 2/3 | 3 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 80 |
| Recruiting | 46 |
| Not yet recruiting | 41 |
| Completed | 21 |
| Active, not recruiting | 8 |
| Terminated | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 126 |
| Cardiovascular | 33 |
| Respiratory | 23 |
| Metabolic and endocrine (diabetes, obesity) | 3 |
| Immunology and rheumatology | 1 |
| Nephrology and urology | 1 |
Countries
| Country | Trials |
|---|---|
| China | 157 |
| France | 2 |
| Italy | 2 |
| Hong Kong SAR China | 1 |
| Netherlands | 1 |
| Taiwan | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-22 | New trial posted | Pulsed Field Ablation for the Treatment of Malignant Lung Tumors |
| 2026-09-21 | New trial posted | Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Resid… |
| 2026-09-21 | New trial posted | 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Maligna… |
| 2026-09-10 | New trial posted | Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophage… |
| 2026-09-08 | New trial posted | 18G Ultrafine Cryoablation Needle for Coaxial Biopsy and Cryoablation of Pulmonary Nodules |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05078931 | A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients | Phase 2 | Active, not recruiting | China |
| NCT07091305 | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients… | Phase 2 | Recruiting | China |
| NCT06962436 | RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs | Not applicable | Recruiting | China |
| NCT06358222 | Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA… | Not applicable | Recruiting | China |
| NCT04135664 | Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carc… | Phase 3 | Recruiting | China |
| NCT05271916 | First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutat… | Phase 1/2 | Recruiting | China |
| NCT06965829 | The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC | Phase 2 | Not yet recruiting | China |
| NCT07331727 | Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation | Not applicable | Not yet recruiting | China |
| NCT07515027 | Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoraco… | Not applicable | Recruiting | China |
| NCT05701787 | Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations | Not applicable | Recruiting | China |
| NCT06982924 | A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertini… | Phase 2 | Not yet recruiting | |
| NCT07036614 | The Novel Special Light for Endotracheal/Bronchial Lesions. | Not applicable | Recruiting | China |
| NCT06453889 | Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung Cancer | Not applicable | Not yet recruiting | China |
| NCT06659042 | Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer | Phase 2 | Recruiting | China |
| NCT05798845 | The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung… | Phase 2 | Recruiting | China |
| NCT06913569 | EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE | Not applicable | Recruiting | China |
| NCT07565532 | Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Invo… | Not applicable | Recruiting | China |
| NCT06633523 | Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF | Not applicable | Not yet recruiting | |
| NCT07135297 | Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules | Not applicable | Not yet recruiting | China |
| NCT07357623 | Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors | Phase 2 | Recruiting | China |
| NCT07060378 | A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes | Not applicable | Recruiting | China |
| NCT06152107 | A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema | Not applicable | Recruiting | China |
| NCT07076693 | Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small C… | Phase 2/3 | Active, not recruiting | China |
| NCT07281209 | A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small… | Phase 2 | Not yet recruiting | |
| NCT06469060 | Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Not yet recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Shanghai Chest Hospital clinical trials: 95 open, 12 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/shanghai-chest-hospital/, data as of 2026-10-25.